AI in Hospitality

Showing 3929 articles
Business

AbCellera Biologics: A Valuation Crossroads After Volatile Returns

Shares of antibody discovery firm AbCellera Biologics (ABCL) present a complex picture for investors, with strong one-year gains overshadowed by steep declines over longer horizons. As the stock trades near $3.86, a significant gap emerges between its market price and some analyst fair value estimates, raising questions about its premium valuation in a challenging biotech market.

Business

Metro AG's Stock Surge Sparks Valuation Debate: Deep Discount or Value Trap?

Shares of German wholesaler Metro AG (HMSE:B4B) have gained momentum in recent months, climbing nearly 5% over the last quarter. This rally, coupled with a discounted cash flow analysis suggesting significant upside, has analysts and investors questioning whether the market is overlooking a bargain or correctly pricing in the challenges facing the cash-and-carry giant.